Latest On ULURU Inc (ULUR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-12-04 06:28 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-27 00:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 21:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 16:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 16:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 21:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 23:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 20:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 04:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 07:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 16:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 08:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 09:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-07 19:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-05 15:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 19:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 04:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-14 03:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 11:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 04:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 09:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 23:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 20:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 07:34 EST | Financials | Company financials have been released. | Neutral | |
About ULURU Inc (ULUR):
ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas.
General
- Name ULURU Inc
- Symbol ULUR
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 2
- Last Split Factor10:1
- Last Split Date2020-03-23
- Fiscal Year EndDecember
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.uluruinc.info
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 18.11
- Price/Book (Most Recent Quarter) 2.37
- Enterprise Value Revenue 18.09
View More
Financials
- Most Recent Quarter 2018-09-30
- Operating Margin -322%
- Return on Assets -14%
- Return on Equity -41%
- Revenue 568744
- Earnings Per Share -$0.01
- Revenue Per Share $0.03
- Gross Profit 487465
- Quarterly Earnings Growth -57.9%
View More
Highlights
- Market Capitalization 10.29 million
- EBITDA -1356503
- Book Value Per Share $0.22
View More
Share Statistics
- Shares Outstanding 20.13 million
- Shares Float 6.67 million
- % Held by Insiders <1%
- % Held by Institutions 0.25%
- Shares Short 2034
- Shares Short Prior Month 2710
- Short Ratio 0.08
View More
Technicals
- Beta -2.98
- 52 Week High $1.1
- 52 Week Low $0.11
- 50 Day Moving Average 0.35
- 200 Day Moving Average 0.52
View More
Dividends
- Dividend Date 2020-03-23
- ExDividend Date N/A
- Dividend Yield 0%
View More
ULURU Inc (ULUR) Dividend Calendar:
ULUR's last dividend payment was made to shareholders on March 23, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
ULURU Inc (ULUR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2018-09-30 | 2018-11-13 | $84612 | $-0.00 | ||
| 2018-06-30 | 2018-09-30 | $105550 | -$0.03 | ||
| 2018-03-31 | 2018-06-30 | $83795 | -$0.03 | ||
| 2017-12-31 | 2018-03-31 | $294787 | -$0.03 | ||
| 2017-09-30 | 2017-12-31 | $201000 | -$0.02 | ||
| 2017-06-30 | 2017-09-30 | $4000 | -$0.03 | ||
| 2017-03-31 | 2017-06-30 | $217000 | -$0.07 | ||
| 2016-12-31 | 2017-03-31 | $64000 | -$0.07 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $6000 | -$0.41 | ||
| 2016-06-30 | 2016-09-30 | $264000 | -$0.11 | ||
| 2016-03-31 | 2016-06-30 | $109000 | -$0.09 | ||
| 2015-12-31 | 2016-03-31 | $358000 | -$0.17 | ||
| 2015-09-30 | 2015-12-31 | $24000 | -$0.12 | ||
| 2015-06-30 | 2015-09-30 | $259000 | -$0.35 | ||
| 2015-03-31 | 2015-06-30 | $295000 | -$0.29 | ||
| 2014-12-31 | 2015-03-31 | $230000 | -$0.30 | $0.00 | |
| 2014-09-30 | 2014-12-31 | $323000 | $0.13 | ||
| 2014-06-30 | 2014-09-30 | $209000 | -$0.28 | ||
| 2014-03-31 | 2014-06-30 | $102000 | -$0.29 | ||
| 2013-12-31 | 2014-03-31 | $129000 | -$0.41 | $0.00 | |
| 2013-09-30 | 2013-12-31 | $111000 | -$0.48 | ||
| 2013-06-30 | 2013-09-30 | $29000 | -$0.48 | ||
| 2013-03-31 | 2013-06-30 | $102000 | -$0.61 | ||
| 2012-12-31 | 2013-03-31 | $166000 | -$0.57 | $0.00 | |
| 2012-09-30 | 2012-12-31 | $89000 | -$1.03 | ||
| 2012-06-30 | 2012-09-30 | $56000 | -$1.05 | ||
| 2012-03-31 | 2012-06-30 | $60000 | -$1.08 | ||
| 2011-12-31 | 2012-03-31 | $256000 | -$1.07 | $0.00 | |
| 2011-09-30 | 2011-12-31 | $73000 | -$1.28 | ||
| 2011-06-30 | 2011-09-30 | $81000 | -$1.75 | ||
| 2011-03-31 | 2011-06-30 | $75000 | -$1.74 | ||
| 2010-12-31 | 2011-03-31 | $1.03 million | -$2.00 | ||
| 2010-09-30 | 2010-12-31 | $61000 | -$0.54 | ||
| 2010-06-30 | 2010-08-17 | $232000 | -$0.41 | ||
| 2010-03-31 | 2010-05-14 | $235000 | -$0.24 | ||
| 2009-12-31 | 2010-03-24 | $232000 | -$0.45 | ||
| 2009-09-30 | 2009-11-16 | $131000 | -$0.35 | ||
| 2009-06-30 | 2009-08-14 | $136000 | -$6.00 | ||
| 2009-03-31 | 2009-05-15 | $169000 | -$7.50 | ||
| 2008-12-31 | 2009-03-30 | $257000 | -$6.00 | ||
| 2008-09-30 | 2008-11-10 | $125000 | -$6.00 | ||
| 2008-06-30 | 2008-08-11 | $95000 | -$0.56 | ||
| 2008-03-31 | 2008-05-12 | $256000 | -$0.44 | ||
| 2007-09-30 | 2007-11-13 | $130000 | -$3.00 | -$1.50 | -100% |
| 2007-06-30 | 2007-08-13 | $118000 | -$3.00 | -$1.50 | -100% |
| 2007-03-31 | 2007-05-30 | $384000 | -$0.21 |
ULURU Inc (ULUR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2018 | Jun 30 2018 | Mar 31 2018 | Dec 31 2017 | Sep 30 2017 |
|---|---|---|---|---|---|
| Research Development | 76889 | 37500 | 45376 | 41333 | 91000 |
| Income Before Tax | -649726 | -585110 | -575415 | -392257 | -538245 |
| Selling General Administrative | 378955 | 355482 | 376360 | 429573 | 405000 |
| Gross Profit | 53213 | 61794 | 57440 | 212518 | 135795 |
| Ebit | -522379 | -449696 | -481560 | -378136 | -398163 |
| Operating Income | -522379 | -449696 | -481560 | -378136 | -398163 |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | 84612 | 105550 | 83795 | 294787 | 201000 |
| Cost of Revenue | 31399 | 43756 | 26355 | 82269 | 74000 |
| Total Other Income Expense Net | -127347 | -135414 | -93855 | -14121 | -140082 |
| Net Income From Continuing Operations | -649726 | -585110 | -575415 | -392257 | -538245 |
| Net Income Applicable to Common Shares | -649726 | -585110 | -575415 | -392257 | -538245 |
Cash Flow:
| Date | Sep 30 2018 | Jun 30 2018 | Mar 31 2018 | Dec 31 2017 | Sep 30 2017 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 15408 | -35531 | -6117 | -627494 | -334837 |
| Total Cash Flow from Investing Activities | 29000 | 29000 | 29179 | 29179 | 29179 |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | 5.88 million | 5.88 million |
| Change to Operating Activities | 341 | 73331 | 71279 | 8984 | -76879 |
| Change in Cash | -333176 | -205453 | -359210 | -893123 | -850556 |
| Total Cash from Operating Activities | -333176 | -205453 | -388389 | -893123 | -850556 |
| Depreciation | 119748 | 118508 | 117264 | 119748 | 119749 |
| Other Cash Flow from Investing Activities | N/A | N/A | 29179 | 29179 | 29179 |
| Change to Inventory | 35492 | 30252 | 9292 | 639 | 62000 |
| Change to Account Receivables | 48745 | 98481 | -63696 | -92587 | -160925 |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | -84339 | -84339 |
| Change to Net Income | 6796 | 5610 | -28990 | -28990 | -774 |
| Capital Expenditures | N/A | N/A | N/A | 4000 | 4000 |
Balance Sheet:
| Date | Sep 30 2018 | Jun 30 2018 | Mar 31 2018 | Dec 31 2017 | Sep 30 2017 |
|---|---|---|---|---|---|
| Total Liabailities | 2.74 million | 2.62 million | 2.53 million | 2.44 million | 2.94 million |
| Total Stockholder Equity | 4.34 million | 4.98 million | 5.56 million | 6.11 million | 6.5 million |
| Other Current Liabilities | 49027 | 29227 | 31118 | 35761 | 263000 |
| Total Assets | 7.08 million | 7.6 million | 8.09 million | 8.54 million | 9.44 million |
| Common Stock | 201349 | 201349 | 201349 | 201349 | 201000 |
| Other Current Assets | 134000 | 112000 | 138000 | 171000 | 144000 |
| Retained Earnings | -64.43 million | -63.78 million | -63.2 million | -62.65 million | -62.26 million |
| Other Liabilities | 331800 | 331800 | 331800 | 352698 | 355000 |
| Other Assets | 4666 | 4316 | 19633 | 18069 | 3.97 million |
| Cash | 2.81 million | 3.15 million | 3.35 million | 3.71 million | 4.6 million |
| Total Current Liabilities | 2.41 million | 2.28 million | 2.2 million | 1.51 million | 2.1 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 37282 | 42763 | 48243 | 53723 | 59000 |
| Total Current Assets | 3.54 million | 3.94 million | 4.3 million | 4.64 million | 5.41 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 839508 | 1.37 million | 1.83 million | 2.27 million | 2.55 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | 570189 | 480000 |
| Inventory | 422425 | 457917 | 488169 | 497461 | 498000 |
| Accounts Payable | 1.17 million | 1.17 million | 1.21 million | 1.21 million | 1.84 million |
ULURU Inc (ULUR) Chart:
ULURU Inc (ULUR) News:
Below you will find a list of latest news for ULURU Inc (ULUR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
ULURU Inc (ULUR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
ULURU Inc (ULUR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2019-11-25 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1168220/000116822019000001/0001168220-19-000001-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1168220/000114036119002500/0001140361-19-002500-index.htm |
| 2019-03-01 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004248/0001140361-19-004248-index.htm |
| 2019-03-01 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004252/0001140361-19-004252-index.htm |
| 2019-03-01 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004253/0001140361-19-004253-index.htm |
| 2019-03-01 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004256/0001140361-19-004256-index.htm |
| 2019-03-01 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004257/0001140361-19-004257-index.htm |
| 2019-03-01 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004258/0001140361-19-004258-index.htm |
| 2019-03-01 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004260/0001140361-19-004260-index.htm |
| 2019-03-01 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004261/0001140361-19-004261-index.htm |
| 2019-03-01 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004262/0001140361-19-004262-index.htm |
| 2019-03-01 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004263/0001140361-19-004263-index.htm |
| 2019-03-01 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004264/0001140361-19-004264-index.htm |
| 2019-03-01 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004266/0001140361-19-004266-index.htm |
| 2019-03-01 | 15-12G | Securities registration termination [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/1168220/000114036119004267/0001140361-19-004267-index.htm |
| 2017-04-17 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000020/0001168220-17-000020-index.htm |
| 2017-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000024/0001168220-17-000024-index.htm |
| 2017-06-01 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000028/0001168220-17-000028-index.htm |
| 2017-06-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000034/0001168220-17-000034-index.htm |
| 2017-06-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000035/0001168220-17-000035-index.htm |
| 2017-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000040/0001168220-17-000040-index.htm |
| 2017-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000046/0001168220-17-000046-index.htm |
| 2017-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000048/0001168220-17-000048-index.htm |
| 2017-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1168220/000116822017000050/0001168220-17-000050-index.htm |
| 2018-03-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000004/0001168220-18-000004-index.htm |
| 2018-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000008/0001168220-18-000008-index.htm |
| 2018-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000011/0001168220-18-000011-index.htm |
| 2018-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000014/0001168220-18-000014-index.htm |
| 2018-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000015/0001168220-18-000015-index.htm |
| 2018-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000017/0001168220-18-000017-index.htm |
| 2018-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000021/0001168220-18-000021-index.htm |
| 2018-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000025/0001168220-18-000025-index.htm |
| 2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000031/0001168220-18-000031-index.htm |
| 2018-12-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1168220/000116822018000033/0001168220-18-000033-index.htm |
| 2019-11-25 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1168220/000116822019000001/0001168220-19-000001-index.htm |
| 2017-04-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1168220/000157104917003560/0001571049-17-003560-index.htm |
| 2017-04-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1168220/000157104917003561/0001571049-17-003561-index.htm |
| 2019-03-05 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1168220/999999999519000363/9999999995-19-000363-index.htm |
| 2019-03-05 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1168220/999999999519000364/9999999995-19-000364-index.htm |
| 2019-03-05 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1168220/999999999519000365/9999999995-19-000365-index.htm |
| 2019-03-05 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1168220/999999999519000366/9999999995-19-000366-index.htm |